emilylevitch_i3Health (@EmilyLevitch) profile picture

Assistant Editor at @i3health oncology news & perspectives (https://teapaw.org/t.co/4biYDGkQ9A) sharing the latest news on clinical trials, expert perspectives, & more!

Joined May 2019
Magnetic resonance imaging with targeted biopsy was shown to be just as effective at detecting prostate cancer compared with TRUS biopsy: @Sunnybrook oncologydataadvisor.com/news… #oncology
1
1
Pembrolizumab continually provides significant survival benefits compared with docetaxel for #patients with advanced #NSCLC five years after initial treatment: @DrRoyHerbstYale @IASLC i3health.us/news/pembrolizum…
1
1
emilylevitch_i3Health retweeted
#Nivolumab improves survival for patients with relapsed malignant #mesothelioma and has a tolerable safety profile, according to results presented by @Dean_Fennell of @LeicResearch at @IASLC #WCLC20: i3health.us/news/nivolumab-e…
2
4
According to a recent study, patients with de novo SCC are at an increased risk of mortality compared to those with inverted papilloma-associated SCC: @WUSTLmed i3health.us/news/pathogenesi… #oncology #SCC
1
1
emilylevitch_i3Health retweeted
In patients undergoing surgery for #colorectal cancer, a low incidence of #COVID19 infection was observed during the postoperative period: i3health.us/news/colorectal-… @CHURouen
2
2
In this interview, @KoheiShitara shares his insights on the #FDA approval of fam-trastuzumab deruxtecan-nxki for #gastriccancer: i3health.us/news/kohei-shita…
3
7
emilylevitch_i3Health retweeted
#Nivolumab plus #cabozantinib is now FDA approved for patients with advanced #renal cell carcinoma (#RCC): i3health.us/news/advanced-re… @DrChoueiri @DanaFarber_GU
3
6
emilylevitch_i3Health retweeted
In this interview, Samuel Washington III, MD, MAS (@SamWashUro) of @UCSFUrology, discusses ways to reduce geographic variation in the use of active surveillance for low-risk #prostate cancer: i3health.us/news/understandi…
2
5
Researchers found that disease spread for #mRCC may vary based on histologic variant, and the location of disease spread is associated with overall survival @UCalgaryMed Read more here: i3health.us/news/renal-cell-…
1
1
The FDA approved fam-trastuzumab deruxtecan-nxki for patients with metastatic HER2-positive gastric cancer previously treated with a trastuzumab-based regimen: i3health.us/news/fam-trastuz… @KoheiShitara #gastriccancer #cancer #oncology #FDA
1
1
2
emilylevitch_i3Health retweeted
#Daratumumab/hyaluronidase has been approved in combination with bortezomib, cyclophosphamide, and dexamethasone for patients with newly diagnosed light chain #amyloidosis. Read more about the @RoyalFreeNHS Phase 3 ANDROMEDA study and approval here: ow.ly/zdy750DcsE9.
1
1
In study results to be presented at the 2021 Gastrointestinal Cancers Symposium, anlotinib demonstrated efficacy in patients with previously treated mCRC: i3health.us/news/anlotinib-e… #GI21 #ASCOGI21
1
2
Researchers found that in patients with nonmetastatic, unresectable PDAC severe lymphopenia can potentially be prevented by lowering the radiotherapy dose: i3health.us/news/locally-adv… @MassGeneralNews #pancreaticcancer #oncology #oncologist #ACCME #lymphopenia #radiotherapy
1
1
A study found that marital status, having higher levels of pain, SOAPP score, and MEDD had influence on whether a patient is likely to develop NMOU: @MDAndersonNews i3health.us/news/what-is-the… #ACCME #oncology #opioids #opioidcrisis #opioid #Cancer
1
2
emilylevitch_i3Health retweeted
Older patients with a history of #breast cancer have a higher risk of developing #cardiovascular disease compared with those without cancer: i3health.us/news/breast-canc… @_tony_matthews @karolinskainst
2
3
In those who survived childhood cancer, an unhealthy lifestyle can compound the risk of cardiovascular disease that can result from intensive cancer therapies: @ISPMBern i3health.us/news/physical-ac… #childhoodcancer #cancer #cardiovascular
1
2
emilylevitch_i3Health retweeted
In this interview, Neal Shore, MD, FACS, of @AtlanticUrology, discusses the recent #FDA approval of #relugolix for patients with advanced #prostate cancer: i3health.us/news/neal-shore-…
2
3
emilylevitch_i3Health retweeted
i3 Health would like to wish everyone a Healthy and Happy New Year. We truly appreciate all that our healthcare workers do for us! As we close out 2020 we have compiled our top 10 featured articles & podcasts- conta.cc/38UoKmZ. #CME #2021 #oncology
3
5
emilylevitch_i3Health retweeted
@BERGONIE33 @AFUrologie @GETUG_Unicancer @SO_Bordeaux #France – at Bordeaux, France
Paul Sargos, MD, discusses the significance of adjuvant radiotherapy versus salvage radiotherapy for prostate cancer in this interview: @BERGONIE33 @PaulSargos i3health.us/news/paul-sargos… #astro20 #prostatecancer #prostate #radiotherapy #CancerResearch
1
1
The FDA has recently expanded approval for selinexor to include combination therapy with bortezomib and dexamethasone for adults with MM: @DanaFarber i3health.us/news/expanded-ap… #FDA #hematology #oncology #MultipleMyeloma
1
1